{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:11:35Z","timestamp":1792714295399,"version":"4.5.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007219","name":"Shanghai Municipal Natural Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007219","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ejmech.2026.118731","type":"journal-article","created":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T15:51:01Z","timestamp":1772207461000},"page":"118731","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Optimization of the fragment binding to hinge region for a potent PIM kinase inhibitor based on N-pyridinyl amide scaffold"],"prefix":"10.1016","volume":"309","author":[{"given":"Mingzhu","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haifeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weidong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianze","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingli","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongtai","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6956-4504","authenticated-orcid":false,"given":"Yun","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2720-9536","authenticated-orcid":false,"given":"Yaming","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2026.118731_bib1","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1126\/science.1075762","article-title":"The protein kinase complement of the human genome","volume":"298","author":"Manning","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2026.118731_bib2","doi-asserted-by":"crossref","DOI":"10.4061\/2011\/794089","article-title":"Regulation and function of protein kinases and phosphatases","volume":"2011","author":"Cheng","year":"2011","journal-title":"Enzym. Res."},{"key":"10.1016\/j.ejmech.2026.118731_bib3","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1111\/cbdd.14024","article-title":"Designing of kinase Hinge binders: a medicinal chemistry perspective","volume":"100","author":"Sharma","year":"2022","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2026.118731_bib4","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1517\/17460441.2012.727394","article-title":"Insights from Pim1 structure for anti-cancer drug design","volume":"7","author":"Ogawa","year":"2012","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.ejmech.2026.118731_bib5","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1021\/acsmedchemlett.3c00212","article-title":"How ligands interact with the kinase Hinge","volume":"14","author":"Zhao","year":"2023","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2026.118731_bib6","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1111\/bph.13096","article-title":"Ten things you should know about protein kinases: IUPHAR review 14","volume":"172","author":"Fabbro","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.118731_bib7","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/anie.202011295","article-title":"Fragment binding to kinase Hinge: if charge distribution and local pK(a) shifts mislead popular bioisosterism concepts","volume":"60","author":"Oebbeke","year":"2021","journal-title":"Angew Chem. Int. Ed. Engl."},{"key":"10.1016\/j.ejmech.2026.118731_bib8","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1016\/j.drudis.2020.09.017","article-title":"Pim kinase inhibitors in cancer: medicinal chemistry insights into their activity and selectivity","volume":"25","author":"Alnabulsi","year":"2020","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2026.118731_bib9","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.3324\/haematol.2009.017079","article-title":"PIM serine\/threonine kinases in the pathogenesis and therapy of hematologic malignancies and solid cancers","volume":"95","author":"Brault","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.ejmech.2026.118731_bib10","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41392-020-0109-y","article-title":"PIM kinase inhibition: co-targeted therapeutic approaches in prostate cancer","volume":"5","author":"Luszczak","year":"2020","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.ejmech.2026.118731_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbagen.2021.129995","article-title":"Therapeutic targeting of PIM KINASE signaling in cancer therapy: structural and clinical prospects","volume":"1865","author":"Rathi","year":"2021","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"10.1016\/j.ejmech.2026.118731_bib12","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/med.21284","article-title":"The PIM family of serine\/threonine kinases in cancer","volume":"34","author":"Narlik-Grassow","year":"2014","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2026.118731_bib13","doi-asserted-by":"crossref","first-page":"4304","DOI":"10.3390\/cancers13174304","article-title":"PIM kinases in multiple myeloma","volume":"13","author":"Wu","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ejmech.2026.118731_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.116016","article-title":"Targeting PIM kinases in cancer therapy: an update on pharmacological small-molecule inhibitors","volume":"264","author":"Chen","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118731_bib15","article-title":"Topical advances in PIM kinases and their inhibitors: medicinal chemistry perspectives","volume":"1877","author":"Walhekar","year":"2022","journal-title":"Biochim. Biophys. Acta Rev. Canc"},{"key":"10.1016\/j.ejmech.2026.118731_bib16","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ejmech.2019.03.050","article-title":"PIM kinase inhibitors: structural and pharmacological perspectives","volume":"172","author":"Asati","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118731_bib17","doi-asserted-by":"crossref","first-page":"41675","DOI":"10.1074\/jbc.M510711200","article-title":"Structure and substrate specificity of the Pim-1 kinase","volume":"280","author":"Bullock","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2026.118731_bib18","doi-asserted-by":"crossref","first-page":"13728","DOI":"10.1074\/jbc.M413155200","article-title":"Pim-1 ligand-bound structures reveal the mechanism of serine\/threonine kinase inhibition by LY294002","volume":"280","author":"Jacobs","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2026.118731_bib19","doi-asserted-by":"crossref","first-page":"5410","DOI":"10.3390\/ijms20215410","article-title":"Insights into the interaction mechanisms of the proviral integration site of moloney murine leukemia virus (pim) kinases with pan-pim inhibitors PIM447 and AZD1208: a molecular dynamics simulation and MM\/GBSA calculation study","volume":"20","author":"Chen","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"Suppl 2","key":"10.1016\/j.ejmech.2026.118731_bib20","first-page":"S317","article-title":"Biological effects of the pim kinase inhibitor, SGI-1776, in multiple myeloma, clin. Lymphoma. Myeloma","volume":"13","author":"Cervantes-Gomez","year":"2013","journal-title":"Leukos"},{"key":"10.1016\/j.ejmech.2026.118731_bib21","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1182\/blood-2013-04-495366","article-title":"AZD1208, a potent and selective pan-Pim kinase inhibitor, demonstrates efficacy in preclinical models of acute myeloid leukemia","volume":"123","author":"Keeton","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.ejmech.2026.118731_bib22","doi-asserted-by":"crossref","first-page":"8373","DOI":"10.1021\/acs.jmedchem.5b01275","volume":"58","author":"Burger","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118731_bib23","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.clml.2023.05.002","article-title":"Phase 1\/2 study of the Pan-PIM kinase inhibitor INCB053914 alone or in combination with standard-of-care agents in patients with advanced hematologic malignancies, clin. Lymphoma","volume":"23","author":"Patel","year":"2023","journal-title":"Myeloma. Leuk."},{"key":"10.1016\/j.ejmech.2026.118731_bib24","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1182\/blood-2010-12-323022","article-title":"Mechanisms of cytotoxicity to pim kinase inhibitor, SGI-1776, in acute myeloid leukemia","volume":"118","author":"Chen","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.ejmech.2026.118731_bib25","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.neo.2014.05.004","article-title":"A small-molecule inhibitor of PIM kinases as a potential treatment for urothelial carcinomas","volume":"16","author":"Foulks","year":"2014","journal-title":"Neoplasia"},{"key":"10.1016\/j.ejmech.2026.118731_bib26","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1038\/s41416-018-0082-1","article-title":"Phase I studies of AZD1208, a proviral integration moloney virus kinase inhibitor in solid and haematological cancers","volume":"118","author":"Cortes","year":"2018","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ejmech.2026.118731_bib27","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s12185-021-03096-9","article-title":"A phase I, dose-escalation study of oral PIM447 in Japanese patients with relapsed And\/or refractory multiple myeloma","volume":"113","author":"Iida","year":"2021","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.ejmech.2026.118731_bib28","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1038\/s41375-019-0482-0","article-title":"The first-in-human study of the pan-PIM kinase inhibitor PIM447 in patients with relapsed and\/or refractory multiple myeloma","volume":"33","author":"Raab","year":"2019","journal-title":"Leukemia"},{"key":"10.1016\/j.ejmech.2026.118731_bib29","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1021\/ml400307j","article-title":"Structure guided optimization, in vitro activity, and in vivo activity of Pan-PIM kinase inhibitors","volume":"4","author":"Burger","year":"2013","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2026.118731_bib30","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1016\/j.bmcl.2016.03.037","article-title":"Design, synthesis and structure activity relationship of potent pan-PIM kinase inhibitors derived from the pyridyl carboxamide scaffold","volume":"26","author":"Nishiguchi","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2026.118731_bib31","doi-asserted-by":"crossref","first-page":"14885","DOI":"10.1021\/acs.jmedchem.0c01279","article-title":"Synthesis and structure-activity relationship of tetra-substituted cyclohexyl diol inhibitors of proviral insertion of moloney virus (PIM) kinases","volume":"63","author":"Han","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118731_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115514","article-title":"Discovery of a high potent PIM kinase inhibitor for acute myeloid leukemia based on N-pyridinyl amide scaffold by optimizing the fragments toward to Lys67 and Asp128\/Glu171","volume":"257","author":"Xiang","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118731_bib33","article-title":"Photocaging of N-pyridinyl amide scaffold-based PIM inhibitors for spatiotemporal controlled anticancer bioactivity","author":"Lu","year":"2025","journal-title":"Bioorg. Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426001765?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426001765?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T21:14:49Z","timestamp":1784668489000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426001765"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":33,"alternative-id":["S0223523426001765"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.118731","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimization of the fragment binding to hinge region for a potent PIM kinase inhibitor based on N-pyridinyl amide scaffold","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.118731","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118731"}}